News

Maxwellia appoints Ian Adamson as Strategic Advisor

Maxwellia has appointed Ian Adamson as strategic advisor to shape the next phase of pharmacy medicine launches – a process which involves identifying and converting suitable prescription only medicines into versions people can choose to...

Catapult Ventures records 3.3x return from exit of Panthera Biopartners

28 April 2022 - Manchester, UK.  The GM&C Life Sciences Fund, managed by Catapult Ventures, has announced a 3.3x cash return (115.6% IRR), from its exit of Panthera Biopartners Ltd. The exit comes as part of a £10m further funding...

Medicine switching expert Maxwellia continues to drive shift to self-care with two more pharmacy products in the launch pipeline

MANCHESTER, England, April 22, 2022 /PRNewswire/ -- Following the reclassification of the daily progestogen-only pill earlier this year, Maxwellia made history by launching Lovima® (desogestrel 75mcg) one of the first oral...

Proveca announces agreement with Biopas Laboratories

Proveca Ltd is excited to announce a significant agreement outside Europe with Biopas Laboratories based in Colombia.  Biopas will commercialise and distribute Sialanar® exclusively throughout Spanish speaking territories in South Am...

Cell Guidance Systems and Manchester BIOGEL Collaborate to Launch PODS-PeptiGels for 3D Cell Culture

CAMBRIDGE & MANCHESTER, England--(BUSINESS WIRE)--Cell Guidance Systems Ltd, a specialist in the control, manipulation, and monitoring of cells, both in vitro and in vivo, and Manchester BIOGEL, a biotechnology company specialis...

From our portfolio

Proveca

Pharmaceuticals

viewview our portfolio

Our Team

Dr Gareth King

view complete team

Contact us

Tel: 01625 344300

email